Technique of Per-Operative Radiotherapy (RPO) by Papillon +TM in Localized Breast Cancer (NCT03121469) | Clinical Trial Compass
CompletedNot Applicable
Technique of Per-Operative Radiotherapy (RPO) by Papillon +TM in Localized Breast Cancer
France28 participantsStarted 2018-10-25
Plain-language summary
Phase 1/2 study, open, monocenter, non-randomized
Who can participate
Age range60 Years
SexFEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Patient with grade 1 or 2 invasive ductal adenocarcinoma or ductal carcinoma in situ, regardless of grade (found on mammography by an outbreak of Single microcalcification with a diameter not exceeding 2 cm or a tumor opacity \<2 cm),
* Patient aged 60 years or older (patients 60 years of age in the year may be included);
* Unilateral adenocarcinoma, unifocal, positive HR, non-overexpressed HER-2 - T1 N0 radio-clinical , Operable patient with breast volume compatible with conservative surgery,
* Patients who have been made aware of the information sheet and have given their written signed informed consent.
* Patients benefitting from social health insurance coverage.
Exclusion Criteria:
* Age less than 60 years
* Patient with grade 3 invasive breast carcinoma
* Patient with lymphatic invasion / peri-nerve involvement / vascular emboli
* Metastatic patient
* Multifocal and / or bilateral tumor
* N1 proved by ultrasound guided
* Patient with psychological and / or psychiatric disorders
* Vulnerable patient: a person deprived of liberty by an administrative or judicial decision, a major person who is the object of a legal protection measure or is unable to express his / her consent
What they're measuring
1
Technique of Per-Operative Radiotherapy feasability